VNDA

Vanda Pharmaceuticals
$4.00
+$0.01 (+0.25%)Oct 28, 2026
1.4PoorMoatMint rating

MoatMint rates Vanda Pharmaceuticals (VNDA) 1.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 4.6 out of 10.

Return-78.0%5YRange $3.51 - $18.17
$19.9$13.9$7.8$1.8Nov 21Sep 25Oct 26

Key metrics

The numbers that frame VNDA today
Market cap
$241.85M
Gross margin
93.7%
EV / Sales
0.9
ROIC
-102.3%
Div yield
0%
Debt / equity
0.1
52wk Low
$3.79
52wk High
$9.94

VNDA stock rating

How VNDA scores on quality, value, growth, momentum and financial health
1.4out of 10
Low overallNeutral business, expensive price
Quality4.6
Growth0.8
Momentum2.6
Value1.2
Financial Health1.5

Growth

Revenue and earnings trend for VNDA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about VNDA
Is Vanda Pharmaceuticals a good buy?
No. Vanda Pharmaceuticals has mixed quality and poor momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Vanda Pharmaceuticals is selling at a very high price.
What is the market capitalization of VNDA?
Vanda Pharmaceuticals's market capitalization is $241.85M.
What is the 52-week high for VNDA stock?
The 52-week high for Vanda Pharmaceuticals is $9.94. The current close of $4.00 is 59.8% below that high.
What is the 52-week low for VNDA stock?
The 52-week low for Vanda Pharmaceuticals is $3.79. The current close of $4.00 is 5.5% above that low.
Does VNDA stock pay dividends?
Vanda Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VNDA?
Vanda Pharmaceuticals's Debt / Equity ratio is 0.08.